SADOWSKI; Thorsten

Patent Applications and Registrations

Patent applications and USPTO patent grants for SADOWSKI; Thorsten.The latest application filed is for "growth differentiation factor 15 as biomarker for metformin".

Company Profile

2.16.22

SADOWSKI; Thorsten - Frankfurt am Main DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Growth Differentiation Factor 15 as Biomarker for Metformin App 20210254156 - HESS; Sibylle ; et al.	2021-08-19
Growth differentiation factor 15 as biomarker for metformin Grant 10,975,434 - Hess , et al. April 13, 2	2021-04-13
Growth Differentiation Factor 15 as Biomarker for Metformin App 20190002977 - HESS; Sibylle ; et al.	2019-01-03
3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Grant 9,751,858 - Ruf , et al. September 5, 2	2017-09-05
3-heteroaroylamino-propionic Acid Derivatives And Their Use As Pharmaceuticals App 20160237060 - RUF; Sven ; et al.	2016-08-18
3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Grant 9,353,068 - Ruf , et al. May 31, 2	2016-05-31
Biaryl-propionic acid derivatives and their use as pharmaceuticals Grant 9,199,947 - Ruf , et al. December 1, 2	2015-12-01
Substituted 3-thiazoloamino-propionic acid derivatives and their use as pharmaceuticals Grant 9,174,952 - Ruf , et al. November 3, 2	2015-11-03
Biaryl-propionic acid derivatives and their use as pharmaceuticals Grant 9,150,526 - Ruf , et al. October 6, 2	2015-10-06
Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Grant 9,120,783 - Ruf , et al. September 1, 2	2015-09-01
Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Grant 9,029,559 - Ruf , et al. May 12, 2	2015-05-12
Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Grant 8,962,671 - Ruf , et al. February 24, 2	2015-02-24
Biaryl-Propionic Acid Derivatives and their Use as Pharmaceuticals App 20140296296 - Ruf; Sven ; et al.	2014-10-02
Biaryl-propionic acid derivatives and their use as pharmaceuticals App 20140296239 - Ruf; Sven ; et al.	2014-10-02
Substituted 3-heteroaroylamino-propionic Acid Derivatives And Their Use As Pharmaceuticals App 20140194445 - Ruf; Sven ; et al.	2014-07-10
Substituted 3-heteroaroylamino-propionic Acid Derivatives And Their Use As Pharmaceuticals App 20140135328 - Ruf; Sven ; et al.	2014-05-15
Oxygen-substituted 3-heteroaroylamino-propionic Acid Derivatives And Their Use As Pharmaceuticals App 20140128616 - RUF; Sven ; et al.	2014-05-08
Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Grant 8,669,370 - Ruf , et al. March 11, 2	2014-03-11
Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Grant 8,664,257 - Ruf , et al. March 4, 2	2014-03-04
Use Of Telaprevir And Related Compounds In Atherosclerosis, Heart Failure, Renal Diseases, Liver Diseases Or Inflammatory Diseases App 20130123276 - Ruf; Sven ; et al.	2013-05-16
Use Of Boceprevir And Related Compounds In Atherosclerosis, Heart Failure, Renal Diseases, Liver Diseases Or Inflammatory Diseases App 20130123325 - Ruf; Sven ; et al.	2013-05-16
3-heteroaroylamino-propionic Acid Derivatives And Their Use As Pharmaceuticals App 20130053416 - RUF; Sven ; et al.	2013-02-28
Substituted 3-thiazoloamino-propionic Acid Derivatives And Their Use As Pharmaceuticals App 20130053402 - RUF; Sven ; et al.	2013-02-28
Oxygen-substituted 3-heteroaroylamino-propionic Acid Derivatives And Their Use As Pharmaceuticals App 20130046004 - Ruf; Sven ; et al.	2013-02-21
Substituted 3-heteroaroylamino-propionic Acid Derivatives And Their Use As Pharmaceuticals App 20120252809 - RUF; Sven ; et al.	2012-10-04
Amino-substituted 3-heteroaroylamino-propionic Acid Derivatives And Their Use As Pharmaceuticals App 20120232112 - RUF; Sven ; et al.	2012-09-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.